Markets.com Logo

XBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    2.858$
  • Previous Close
    2.8303$
  • 52 Week Change
    3.07$
  • Day Range
    0.03$
  • 52 Week High/Low
    2.2$ - 5.2683$
  • Dividend Per Share
    --
  • Market cap
    4 349 K$
  • EPS
    -0.45
  • Beta
    2.329
  • Volume
    --

About

XBIO.US represents the ticker symbol for the ProShares UltraShort Nasdaq Biotechnology ETF. This ETF is designed to deliver twice the inverse (opposite) of the daily performance of the Nasdaq Biotechnology Index. Therefore, it is a leveraged bearish investment vehicle that aims to profit from a decline in the value of biotechnology stocks included in the Nasdaq Biotechnology Index. Investors should understand that due to the leveraged nature of the fund and daily resetting, its performance over periods longer than one day may deviate significantly from the stated multiple of the underlying index's return and is not intended for buy-and-hold strategies.
Will DJT skyrocket in 2026: Is DJT stock a good long-term investment?

Will DJT skyrocket in 2026: Is DJT stock a good long-term investment?

Ghko B|--
XRP price analysis: XRP/USD slides, what’s going on with Ripple?

XRP price analysis: XRP/USD slides, what’s going on with Ripple?

Ghko B|--
Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

Why stock market is down: Dow DJIA slides, S&P 500 sinks, Nasdaq dips

Ghko B|--
Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Crypto Trend Insight 2026: XRP Price Movements and Market Analysis

Ghko B|--
AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

AI stocks to watch: Why Broadcom (AVGO) stock, NVDA stock and AMD are down?

Ghko B|--
The rise and fall of gold prices: What’s going on with gold XAU/USD?

The rise and fall of gold prices: What’s going on with gold XAU/USD?

Frances Wang|--
Bitcoin (BTC/USD) today: Bitcoin price under 76K, could BTC keep falling?

Bitcoin (BTC/USD) today: Bitcoin price under 76K, could BTC keep falling?

Frances Wang|--

Factors

Clinical Trial Results: Positive data from clinical trials typically drive the stock price higher, while negative or inconclusive results can lead to a decline.

Regulatory Approvals: FDA approval of XBIObio's products significantly boosts investor confidence and increases stock value.

Competition: The presence and success of competing therapies can negatively impact XBIO's market share and stock price.

Market Sentiment: Overall investor optimism or pessimism towards the biotechnology sector can influence XBIO's stock.

Financial Performance: Strong revenue growth and profitability can attract investors and raise the stock price.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

CFD Trading for Beginners: What to Know about Online Markets & Trading Platforms?

Georgy Istigechev|--
CFD trading basics: Long position VS. short position, which is better?

CFD trading basics: Long position VS. short position, which is better?

Ghko B|--
What is a stochastic indicator: How to read the stochastic indicator?

What is a stochastic indicator: How to read the stochastic indicator?

Ghko B|--